Stocks and Investing Stocks and Investing
Fri, July 21, 2023

Anupam Rama Initiated (TVTX) at Buy and Held Target at $26 on, Jul 21st, 2023


Published on 2024-10-28 05:00:45 - WOPRAI, Anupam Rama
  Print publication without navigation


Anupam Rama of JP Morgan, Initiated "Travere Therapeutics, Inc." (TVTX) at Buy and Held Target at $26 on, Jul 21st, 2023.

Anupam has made no other calls on TVTX in the last 4 months.



There are 9 other peers that have a rating on TVTX. Out of the 9 peers that are also analyzing TVTX, 1 agrees with Anupam's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Nicole Gabreski of "Piper Sandler" Initiated at Hold and Held Target at $22 on, Wednesday, June 7th, 2023


These are the ratings of the 8 analyists that currently disagree with Anupam


  • Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $35 on, Tuesday, July 18th, 2023
  • Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $23 on, Wednesday, June 21st, 2023
  • Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $35 on, Thursday, June 1st, 2023
  • Tyler Van Buren of "TD Cowen" Initiated at Buy and Held Target at $30 on, Monday, May 22nd, 2023
  • Vamil Divan of "Guggenheim" Maintained at Strong Buy with Decreased Target to $23 on, Tuesday, May 2nd, 2023
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Decreased Target to $26 on, Tuesday, May 2nd, 2023
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Decreased Target to $24 on, Tuesday, May 2nd, 2023
  • Greg Harrison of "B of A Securities" Maintained at Strong Buy with Decreased Target to $39 on, Tuesday, May 2nd, 2023

Contributing Sources